In CLL, disruptions to the p53 pathway arise primarily through deletions of chromosomes 17p and 11q containing TP53 and ATM, respectively, and from deleterious mutations affecting these genes [13,14,15,16]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.